Literature DB >> 18050371

The CD40/CD40 ligand system in the skin of patients with subacute cutaneous lupus erythematosus.

Marzia Caproni1, Daniele Torchia, Emiliano Antiga, Barbara Giomi, Michele Mercuri, Walter Volpi, Paolo Fabbri.   

Abstract

OBJECTIVE: To investigate whether CD40 and CD40 ligand (CD40L) is expressed in the skin of patients with subacute cutaneous lupus erythematosus (SCLE).
METHODS: Six female patients with SCLE were studied. Skin biopsies were obtained from lesional and healthy sunprotected skin. Frozen sections were stained immunohistochemically using monoclonal antibodies to CD4, CD40, and CD40L. As controls we used 5 patients with discoid LE (DLE), 5 with dermatomyositis (DM), 3 with lichen planus (LP), and 2 with erythema multiforme (EM), as well as the normal-appearing skin of 5 healthy volunteers.
RESULTS: The CD40 was intensely expressed in all SCLE, DLE, and DM lesions, and only focally in healthy sunprotected skin specimens. The number of CD40+ cells in SCLE dermis was lower than in DLE, similar to that in DM, LP and EM, and higher than in SCLE sunprotected skin. CD40L+ cells infiltrated the SCLE, DLE, DM, LP, and EM lesional dermis, and were more numerous in SCLE lesional skin than in SCLE healthy sunprotected skin.
CONCLUSION: We showed that the CD40/CD40L system may represent an important pathway of induction of SCLE lesions. The expression of such costimulatory system in healthy sunprotected skin also may signify that its abnormal activation is constitutive in SCLE, as previously observed in systemic LE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18050371

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells.

Authors:  Karin Loser; Thomas Vogl; Maik Voskort; Aloys Lueken; Verena Kupas; Wolfgang Nacken; Lars Klenner; Annegret Kuhn; Dirk Foell; Lydia Sorokin; Thomas A Luger; Johannes Roth; Stefan Beissert
Journal:  Nat Med       Date:  2010-05-09       Impact factor: 53.440

2.  Inhibition of CD40-CD154 costimulatory pathway by a cyclic peptide targeting CD154.

Authors:  Ilaria Deambrosis; Sara Lamorte; Fulvia Giaretta; Lorenzo Tei; Luigi Biancone; Benedetta Bussolati; Giovanni Camussi
Journal:  J Mol Med (Berl)       Date:  2008-11-05       Impact factor: 4.599

Review 3.  Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus.

Authors:  Gongjun Tan; Binila Baby; Yuqiu Zhou; Tianfu Wu
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 7.561

4.  Aberrant CD40-induced NF-κB activation in human lupus B lymphocytes.

Authors:  Wen Zhang; Qun Shi; Xiaotian Xu; Hua Chen; Wei Lin; Fengchun Zhang; Xiaofeng Zeng; Xuan Zhang; Denian Ba; Wei He
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

5.  CD40-mediated amplification of local immunity by epithelial cells is impaired by HPV.

Authors:  Bart Tummers; Renske Goedemans; Veena Jha; Craig Meyers; Cornelis J M Melief; Sjoerd H van der Burg; Judith M Boer
Journal:  J Invest Dermatol       Date:  2014-06-19       Impact factor: 8.551

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.